Literature DB >> 2895740

A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen.

B Nowicki1, J Moulds, R Hull, S Hull.   

Abstract

A receptor moiety and blood group substance recognized by the O75X adhesin was studied. Well-defined erythrocytes representing different blood group systems and bacterial derivatives carrying plasmid pBJN406 encoding the adhesin were used in a direct hemagglutination assay. We showed that Dr blood group antigen, a component of the IFC blood group complex, is the receptor for the O75X fimbrialike adhesin (Dr hemagglutinin) of uropathogenic Escherichia coli. The molecule recognized by the Dr hemagglutinin on Dr blood group substance is a chloramphenicol-like structure. The inhibitory effect of the active compounds indicates that a tyrosine-containing molecule could be a natural receptor for the Dr hemagglutinin. Dr blood group substance was found in tubular basement membrane and Bowman's capsule of the human kidney. Specific attachment of a Dr hemagglutinin-positive bacterial strain to the kidney substructures was inhibited by chloramphenicol.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895740      PMCID: PMC259761          DOI: 10.1128/iai.56.5.1057-1060.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Location of adhesion sites for P-fimbriated and for 075X-positive Escherichia coli in the human kidney.

Authors:  B Nowicki; H Holthöfer; T Saraneva; M Rhen; V Väisänen-Rhen; T K Korhonen
Journal:  Microb Pathog       Date:  1986-04       Impact factor: 3.738

2.  Inhibition of the interaction between fimbrial haemagglutinins and erythrocytes by D-mannose and other carbohydrates.

Authors:  D C Old
Journal:  J Gen Microbiol       Date:  1972-06

3.  Blood group M specific haemagglutinin in pyelonephritogenic Escherichia coli.

Authors:  V Väisänen; T K Korhonen; M Jokinen; C G Gahmberg; C Ehnholm
Journal:  Lancet       Date:  1982-05-22       Impact factor: 79.321

Review 4.  Host-specific fimbrial adhesins of noninvasive enterotoxigenic Escherichia coli strains.

Authors:  W Gaastra; F K de Graaf
Journal:  Microbiol Rev       Date:  1982-06

5.  A possible null phenotype in the Cromer blood group complex.

Authors:  G L Daniels; H Tohyama; M Uchikawa
Journal:  Transfusion       Date:  1982 Sep-Oct       Impact factor: 3.157

6.  Inhibition of experimental ascending urinary tract infection by an epithelial cell-surface receptor analogue.

Authors:  C S Edén; R Freter; L Hagberg; R Hull; S Hull; H Leffler; G Schoolnik
Journal:  Nature       Date:  1982-08-05       Impact factor: 49.962

7.  Target cell specificity of wild-type E. coli and mutants and clones with genetically defined adhesins.

Authors:  C Svanborg Edén; R Hull; S Falkow; H Leffler
Journal:  Prog Food Nutr Sci       Date:  1983

8.  Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells.

Authors:  C S Edén; H A Hansson
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

9.  Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis.

Authors:  V Väisänen; J Elo; L G Tallgren; A Siitonen; P H Mäkelä; C Svanborg-Edén; G Källenius; S B Svenson; H Hultberg; T Korhonen
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

10.  Occurrence of P-fimbriated Escherichia coli in urinary tract infections.

Authors:  G Källenius; R Möllby; S B Svenson; I Helin; H Hultberg; B Cedergren; J Winberg
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

View more
  56 in total

1.  Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules.

Authors:  J Guignot; M F Bernet-Camard; C Poüs; L Plançon; C Le Bouguenec; A L Servin
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

2.  Pyelonephritogenic diffusely adhering Escherichia coli EC7372 harboring Dr-II adhesin carries classical uropathogenic virulence genes and promotes cell lysis and apoptosis in polarized epithelial caco-2/TC7 cells.

Authors:  J Guignot; J Breard; M F Bernet-Camard; I Peiffer; B J Nowicki; A L Servin; A B Blanc-Potard
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

3.  The major structural subunits of Dr and F1845 fimbriae are adhesins.

Authors:  Cristina P Van Loy; Evgeni V Sokurenko; Steve L Moseley
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice.

Authors:  B Nowicki; J Singhal; L Fang; S Nowicki; C Yallampalli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Increased rate of apoptosis and diminished phagocytic ability of human neutrophils infected with Afa/Dr diffusely adhering Escherichia coli strains.

Authors:  Patrick Brest; Frédéric Bétis; Nicolas Cuburu; Eric Selva; Magali Herrant; Alain Servin; Patrick Auberger; Paul Hofman
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli.

Authors:  B Nowicki; C Svanborg-Edén; R Hull; S Hull
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

7.  Prophylactic herbal therapy prevents experimental ascending urinary tract infection in mice.

Authors:  Yan-Qing Tong; Min Sun; Ying Chi
Journal:  Chin J Integr Med       Date:  2016-07-19       Impact factor: 1.978

8.  Hydrophilic domain II of Escherichia coli Dr fimbriae facilitates cell invasion.

Authors:  Margaret Das; Audrey Hart-Van Tassell; Petri T Urvil; Susan Lea; David Pettigrew; K L Anderson; Alfred Samet; Jozef Kur; Steve Matthews; Stella Nowicki; Vsevolod Popov; Pawel Goluszko; Bogdan J Nowicki
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

9.  Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin.

Authors:  Pawel Goluszko; Elzbieta Goluszko; Bogdan Nowicki; Stella Nowicki; Vsevolod Popov; Hui-Qun Wang
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

10.  Nonlethal adherence to human neutrophils mediated by Dr antigen-specific adhesins of Escherichia coli.

Authors:  J R Johnson; K M Skubitz; B J Nowicki; K Jacques-Palaz; R M Rakita
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.